Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SABRE: Risedronate for Bone Health in Anastrozole-Treated Breast Cancer
NCT00082277Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by AstraZeneca. Started Apr 2004; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00082277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082277.